| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.4 | 7e-25 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.31 | 6e-20 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-16 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-14 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-13 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-13 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-12 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-11 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-10 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |